Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure
How to buy Veracyte stock
Learn how to easily invest in Veracyte stock.
Veracyte Inc is a biotechnology business based in the US. Veracyte shares (VCYT) are listed on the NASDAQ and all prices are listed in US Dollars. Veracyte employs 761 staff and has a trailing 12-month revenue of around $268.4 million.
How to buy shares in Veracyte
- Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
- Open your brokerage account. Complete an application with your details.
- Confirm your payment details. Fund your account.
- Research the stock. Find the stock by name or ticker symbol – VCYT – and research it before deciding if it's a good investment for you.
- Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
- Check in on your investment. Optimize your portfolio by tracking your stock.
Veracyte stock price (NASDAQ: VCYT)Use our graph to track the performance of VCYT stocks over time.
Veracyte shares at a glance
|Latest market close||$16.58|
|52-week range||$14.85 - $54.13|
|50-day moving average||$22.68|
|200-day moving average||$25.39|
|Wall St. target price||$30.33|
|Dividend yield||$0 (0%)|
|Earnings per share (TTM)||$-0.69|
Buy Veracyte shares from these brokeragesCompare special offers, low fees and a wide range of types of investments among top trading platforms.
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
Is it a good time to buy Veracyte stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Veracyte price performance over time
|1 week (2022-09-19)||-11.00%|
|1 month (2022-08-26)||-22.31%|
|3 months (2022-06-24)||-27.09%|
|6 months (2022-03-22)||-41.12%|
|1 year (2021-09-23)||-68.14%|
|2 years (2020-09-25)||-46.10%|
|3 years (2019-09-26)||24.67|
|5 years (2017-09-26)||92.12%|
|Revenue TTM||$268.4 million|
|Gross profit TTM||$145.1 million|
|Return on assets TTM||-3.73%|
|Return on equity TTM||-4.78%|
|Market capitalisation||$1.2 billion|
TTM: trailing 12 months
Veracyte share dividends
We're not expecting Veracyte to pay a dividend over the next 12 months.
Veracyte share price volatility
Over the last 12 months, Veracyte's shares have ranged in value from as little as $14.85 up to $54.13. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Veracyte's is 1.175. This would suggest that Veracyte's shares are a little bit more volatile than the average for this exchange and represent, relatively-speaking, a slightly higher risk (but potentially also market-beating returns).
Veracyte, Inc. operates as a diagnostics company worldwide. The company offers Afirma Genomic Sequencing Classifier and Xpression Atlas, which are used to determine patients with indeterminate results are benign to avoid unnecessary surgery; Decipher Prostate Biopsy and Radical Prostatectomy for prostate cancer diagnosis; Prosigna Breast Cancer Assay for breast cancer diagnosis; Percepta Genomic Sequencing Classifier and Percepta Nasal Swab Test for lung cancer diagnosis; Envisia Genomic Classifier for diagnosing interstitial lung disease, including idiopathic pulmonary fibrosis; and Immunoscore Colon Cancer test for colon cancer diagnosis. It is also developing Percepta Genomic Atlas to help inform lung cancer treatment decisions; Envisia Classifier, the nCounter analysis system; and LymphMark for lymphoma subtyping test. Veracyte, Inc. has technology licensing and collaboration arrangements with Johnson & Johnson; Acerta Pharma; and CareDx. The company was formerly known as Calderome, Inc.
Veracyte in the news
Should Growth Investors Buy This Little-Known Stock?
New Data Published in JNCI Demonstrate Veracyte’s Decipher Prostate Genomic Classifier May Improve Identification of Aggressive Prostate Cancer in African American Men
Veracyte Names John Leite, Ph.D., as General Manager of Pulmonology & Market Access
Frequently asked questionsWhat percentage of Veracyte is owned by insiders or institutions?
Currently 1.003% of Veracyte shares are held by insiders and 107.172% by institutions. How many people work for Veracyte?
Latest data suggests 761 work at Veracyte. When does the fiscal year end for Veracyte?
Veracyte's fiscal year ends in December. Where is Veracyte based?
Veracyte's address is: 6000 Shoreline Court, South San Francisco, CA, United States, 94080 What is Veracyte's ISIN number?
Veracyte's international securities identification number is: US92337F1075 What is Veracyte's CUSIP number?
Veracyte's Committee on Uniform Securities Identification Procedures number is: 92337F107
More guides on Finder
What are the FAANG stocks and how do you invest in them?
Looking to invest in tech? Here’s how to buy shares in the major tech companies, known as FAANG stocks.
How to buy soccer stocks
A simple guide to buying stocks in your favorite European soccer team.
How to buy Juventus stock
Steps to owning and managing JUVE, with 24-hour and historical pricing before you buy.
How to buy AS Roma stock
Steps to owning and managing ASR, with 24-hour and historical pricing before you buy.
How to buy Borussia Dortmund stock
Steps to owning and managing BVB, with 24-hour and historical pricing before you buy.
How to buy Lead Real Estate Co. (LRE) stock when it goes public
Everything we know about the Lead Real Estate Co. IPO, plus information on how to buy in.
How to buy Third Harmonic Bio (THRD) stock
Everything we know about the Third Harmonic Bio IPO, plus information on how to buy in.
How to buy LINKBANCORP (LNKB) stock
Everything we know about the LINKBANCORP IPO, plus information on how to buy in.
Here are the stocks that benefit from inflation, as well as industries to keep an eye on to reduce the impacts of inflation on your portfolio.
We’ve rounded up stats on some of the most popular wheat stocks, along with information on how these stocks compare and how to invest.
Ask an Expert